Changes of anti-oxidative enzyme and oxidative stress after in a mouse model of kidney fibrosis. by Wencheng Jin (13136262)

Changes related to kidney staining in UUO mouse model. by Wencheng Jin (13136262)

Changes associated with kidney fibrosis in TGF- by Wencheng Jin (13136262)

Validation of MN705 treatment effects in human proximal tubular epithelial cells during TGF- by Wencheng Jin (13136262)

Table 1_Impact of co-infections and immune responses on clinical severity of human adenovirus 3 and 7 infections in hospitalized children with lower respiratory tract infections: a... by Xiaolin Ma (701778)

“…</p>Methods<p>This study involved a retrospective analysis of respiratory specimens collected from enrolled children with lower respiratory tract infections (LRTIs), positive for HAdV-3 or HAdV-7 from January 2017 to December 2019. …”

Bacterial strains used in this study. by Nobuo Fuke (22190368)

“…The proportion of Smurf individuals was significantly lower in <i><i>C. elegans</i></i> fed <i><i>P. copri</i></i> cultured in TJ medium than in those fed the same bacteria cultured in normal medium, while other strains showed no such medium-dependent differences. …”

Effect of MN705 treatment on TGF- by Wencheng Jin (13136262)

The clinical characteristic of patients. by Hai-bo Ai (20790405)

The results of threshold effect analysis. by Hai-bo Ai (20790405)

Prevalence of CSF biomarkers across age. by Sarah J. Neal (20721301)

The forest plot of subgroup analysis. by Hai-bo Ai (20790405)

Sociodemographic characteristics of the sample. by Senay Yildirim-Kahriman (22693464)

“…Statistical analyses included descriptive statistics, Spearman’s correlation, and multiple linear regression. Participants demonstrated significantly higher awareness of scientifically established cancer causes (70.7%) compared to mythical ones (10.2%). …”

The Human Disharmony Loop (central). by James M. Friedman (22522150)

Risk of bias across 22 included studie. by Kuo-Chuan Hung (8587392)

“…Consistently, participants receiving ketamine/esketamine had lower depression-related scores at 1- (standardized mean difference [SMD], −0.94; 95%CI, −1.26 to −0.62) and 4–6-week (SMD, −0.89; 95%CI, −1.25 to −0.53) follow-ups. …”

An overview of the selection process for studies. by Kuo-Chuan Hung (8587392)

“…Consistently, participants receiving ketamine/esketamine had lower depression-related scores at 1- (standardized mean difference [SMD], −0.94; 95%CI, −1.26 to −0.62) and 4–6-week (SMD, −0.89; 95%CI, −1.25 to −0.53) follow-ups. …”

Characteristics of studies (<i>n</i> = 22). by Kuo-Chuan Hung (8587392)

“…Consistently, participants receiving ketamine/esketamine had lower depression-related scores at 1- (standardized mean difference [SMD], −0.94; 95%CI, −1.26 to −0.62) and 4–6-week (SMD, −0.89; 95%CI, −1.25 to −0.53) follow-ups. …”

Development of hamstring strength throughout the LIST. by Dominic Michael Rasp (19959412)

Development of the limb symmetry index (LSI) over the course of the LIST. by Dominic Michael Rasp (19959412)

Fig 3 - by Maha Rehman (17114332)

Patients’ responses to EQ5-D items. by Walid Al-Qerem (3760027)

“…Moreover, patients with only an elementary education had significantly lower EQ5-D scores compared to those with a postgraduate education (-0.106, 95%CI (-0.190, -0.023), p = 0.013).…”